Theory
ROS are known to present serious danger for living cells and whole organisms, especially with age.
Technology
SkQ1 reduces ROS production inside mitochondria in a controlled and sustainable manner.
Results
Several SkQ1-based drugs targeting various age-related disorders are being developed in our labs.